CDER’s New Quality Office Still Awaiting Final Sign Offs
This article was originally published in RPM Report
Executive Summary
FDA’s proposed Office of Pharmaceutical Quality remains a personal and professional priority of CDER Director Janet Woodcock, and she determined to get the office up and running before the end of the fiscal year.